Abstract Details

Title Fahr's disease due to a novel SLC20A2 gene mutation in a Canadian patient: Early Neurocognitive, Structural and Metabolic changes

Topic Behavioral and Cognitive Neurology

Presentation(s) P2 - (-)

Poster/Presentation
Number 175

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Leila Sellami, MD (CSSS de l'Outaouais Hôpital de Hull) PRESENTER	Dr. Sellami has nothing to disclose.
Louis Verret, MD (CHU De Quebec - Universite Laval - Hosp. Enfant-Jesus)	No disclosure on file
Stephane Poulin, MD (Centre Hospitalier Universitaire De Quebec)	No disclosure on file
Robert Laforce, Jr., MD, PhD (CHU De Quebec)	Dr. Laforce has nothing to disclose.